Faizan Anwar

Mr. Faizan Anwar

Midwestern University, Glendale, Arizona, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2022 in Journal of Nanotheranostics
Verified
Journal Article
Open access
PDF file
MHMd Walid Akram Hussain
Md Walid Akram Hussain
Sarah JahangirSarah Jahangir
Sarah Jahangir
BGBikona Ghosh
Bikona Ghosh
Farjana YesminFarjana Yesmin
Farjana Yesmin
AFNAN ANISAFNAN ANIS
AFNAN ANIS
Mohammad Harun RashidMohammad Harun Rashid
Mohammad Harun Rashid
Exosomes are membrane-enveloped nanosized (30–150 nm) extracellular vesicles of endosomal origin produced by almost all cell types and encompass a multitude of functioning biomolecules. Exosomes have been considered crucial players of cell-to-cell communication in physiological and pathological conditions. Accumulating evidence suggests that exosomes can modulate the immune system by delivering a plethora of signals that can either stimulate or suppress immune responses, which have potential applications as immunotherapies for cancer and autoimmune diseases. Here, we discuss the current knowledge about the active biomolecular components of exosomes that contribute to exosomal function in modulating different immune cells and also how these immune cell-derived exosomes play critical roles in immune responses. We further discuss the translational potential of engineered exosomes as immunotherapeutic agents with their advantages over conventional nanocarriers for drug delivery and ongoing clinical trials.

28 October 2021 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
Mohammad Harun RashidMohammad Harun Rashid
Mohammad Harun Rashid
NSNicklaus A. Sparrow
Nicklaus A. Sparrow
FAFaizan Anwar
Faizan Anwar
GGGena Guidry
Gena Guidry
ACAmbart E. Covarrubias
Ambart E. Covarrubias
SLShouri Lahiri
Shouri Lahiri
Background: Urinary tract infection (UTI) is frequently implicated as a precipitant of delirium, which refers to an acute confusional state that is associated with high mortality, increased length of stay, and long-term cognitive decline. The pathogenesis of delirium is thought to involve cytokine-mediated neuronal dysfunction of the frontal cortex and hippocampus. We hypothesized that systemic IL-6 inhibition would mitigate delirium-like phenotypes in a mouse model of UTI.Methods: C57/BL6 mice were randomized to either: (1) non-UTI control, (2) UTI, and (3) UTI + anti-IL-6 antibody. UTI was induced by transurethral inoculation of 1 × 108Escherichia coli. Frontal cortex and hippocampus-mediated behaviors were evaluated using functional testing and corresponding structural changes were evaluated via quantification of neuronal cleaved caspase-3 (CC3) by immunohistochemistry and western blot. IL-6 in the brain and plasma were evaluated using immunohistochemistry, ELISA, and RT-PCR.Results: Compared to non-UTI control mice, mice with UTI demonstrated significantly greater impairments in frontal and hippocampus-mediated behaviors, specifically increased thigmotaxis in Open Field (p < 0.05) and reduced spontaneous alternations in Y-maze (p < 0.01), while treatment of UTI mice with systemic anti-IL-6 fully reversed these functional impairments. These behavioral impairments correlated with frontal and hippocampal neuronal CC3 changes, with significantly increased frontal and hippocampal CC3 in UTI mice compared to non-UTI controls (p < 0.0001), and full reversal of UTI-induced CC3 neuronal changes following treatment with systemic anti-IL-6 antibody (p < 0.0001). Plasma IL-6 was significantly elevated in UTI mice compared to non-UTI controls (p < 0.01) and there were positive and significant correlations between plasma IL-6 and frontal CC3 (r2 = 0.5087/p = 0.0028) and frontal IL-6 and CC3 (r2 = 0.2653,p < 0.0001).Conclusions: These data provide evidence for a role for IL-6 in mediating delirium-like phenotypes in a mouse model of UTI. These findings provide pre-clinical justification for clinical investigations of IL-6 inhibitors to treat UTI-induced delirium.

1 October 2021 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
NSNicklaus A. Sparrow
Nicklaus A. Sparrow
FAFaizan Anwar
Faizan Anwar
ACAmbart E. Covarrubias
Ambart E. Covarrubias
PRPadmesh S. Rajput
Padmesh S. Rajput
Mohammad Harun RashidMohammad Harun Rashid
Mohammad Harun Rashid
SLShouri Lahiri
Shouri Lahiri
Mechanical ventilation is a known risk factor for delirium, a cognitive impairment characterized by dysfunction of the frontal cortex and hippocampus. Although IL-6 is upregulated in mechanical ventilation–induced lung injury (VILI) and may contribute to delirium, it is not known whether the inhibition of systemic IL-6 mitigates delirium-relevant neuropathology. To histologically define neuropathological effects of IL-6 inhibition in an experimental VILI model, VILI was simulated in anesthetized adult mice using a 35 cc/kg tidal volume mechanical ventilation model. There were two control groups, as follow: 1) spontaneously breathing or 2) anesthetized and mechanically ventilated with 10 cc/kg tidal volume to distinguish effects of anesthesia from VILI. Two hours before inducing VILI, mice were treated with either anti–IL-6 antibody, anti–IL-6 receptor antibody, or saline. Neuronal injury, stress, and inflammation were assessed using immunohistochemistry. CC3 (cleaved caspase-3), a neuronal apoptosis marker, was significantly increased in the frontal (P < 0.001) and hippocampal (P < 0.0001) brain regions and accompanied by significant increases in c-Fos and heat shock protein-90 in the frontal cortices of VILI mice compared with control mice (P < 0.001). These findings were not related to cerebral hypoxia, and there was no evidence of irreversible neuronal death. Frontal and hippocampal neuronal CC3 were significantly reduced with anti–IL-6 antibody (P < 0.01 and P < 0.0001, respectively) and anti–IL-6 receptor antibody (P < 0.05 and P < 0.0001, respectively) compared with saline VILI mice. In summary, VILI induces potentially reversible neuronal injury and inflammation in the frontal cortex and hippocampus, which is mitigated with systemic IL-6 inhibition. These data suggest a potentially novel neuroprotective role of systemic IL-6 inhibition that justifies further investigation.

31 May 2020 in Schizophrenia Research
Verified
Journal Article
Closed access
WCWon Jong Chwa
Won Jong Chwa
TTTodd A. Tishler
Todd A. Tishler
CRCatalina Raymond
Catalina Raymond
CTCathy Tran
Cathy Tran
FAFaizan Anwar
Faizan Anwar
BEBenjamin M. Ellingson
Benjamin M. Ellingson

13 September 2022 in Critical Care
Verified
Journal Article
Open access
PDF file
FAFaizan Anwar
Faizan Anwar
NSNicklaus A. Sparrow
Nicklaus A. Sparrow
MRMohammad Harun Rashid
Mohammad Harun Rashid
GGGena Guidry
Gena Guidry
MGMichael M. Gezalian
Michael M. Gezalian
SLShouri Lahiri
Shouri Lahiri
Acute neuropsychiatric impairments occur in over 70% of patients with acute lung injury. Mechanical ventilation is a well-known precipitant of acute lung injury and is strongly associated with the development of acute delirium and anxiety phenotypes. In prior studies, we demonstrated that IL-6 mediates neuropathological changes in the frontal cortex and hippocampus of animals with mechanical ventilation-induced brain injury; however, the effect of systemic IL-6 inhibition on structural and functional acute neuropsychiatric phenotypes is not known. We hypothesized that a murine model of mechanical ventilation-induced acute lung injury (VILI) would induce neural injury to the amygdala and hippocampus, brain regions that are implicated in diverse neuropsychiatric conditions, and corresponding delirium- and anxiety-like functional impairments. Furthermore, we hypothesized that these structural and functional changes would reverse with systemic IL-6 inhibition. VILI was induced using high tidal volume (35 cc/kg) mechanical ventilation. Cleaved caspase-3 (CC3) expression was quantified as a neural injury marker and found to be significantly increased in the VILI group compared to spontaneously breathing or anesthetized and mechanically ventilated mice with 10 cc/kg tidal volume. VILI mice treated with systemic IL-6 inhibition had significantly reduced amygdalar and hippocampal CC3 expression compared to saline-treated animals and demonstrated amelioration in acute neuropsychiatric behaviors in open field, elevated plus maze, and Y-maze tests. Overall, these data provide evidence of a pathogenic role of systemic IL-6 in mediating structural and functional acute neuropsychiatric symptoms in VILI and provide preclinical justification to assess IL-6 inhibition as a potential intervention to ameliorate acute neuropsychiatric phenotypes following VILI.

1 May 2021 in Schizophrenia Research
Verified
Journal Article
Closed access
CWChencai Wang
Chencai Wang
TOTalia Oughourlian
Talia Oughourlian
TTTodd A. Tishler
Todd A. Tishler
FAFaizan Anwar
Faizan Anwar
CRCatalina Raymond
Catalina Raymond
BEBenjamin M. Ellingson
Benjamin M. Ellingson